Nicole Loo

1.1k total citations · 1 hit paper
25 papers, 633 citations indexed

About

Nicole Loo is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Nicole Loo has authored 25 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Hepatology and 3 papers in Surgery. Recurrent topics in Nicole Loo's work include Liver Disease Diagnosis and Treatment (15 papers), Hepatitis C virus research (7 papers) and Liver Disease and Transplantation (4 papers). Nicole Loo is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Hepatitis C virus research (7 papers) and Liver Disease and Transplantation (4 papers). Nicole Loo collaborates with scholars based in United States, United Arab Emirates and India. Nicole Loo's co-authors include Dhruvanshu Parmar, Rizwana Mohseni, Kris V. Kowdley, Pankaj Patel, Samer Gawrieh, Naga Chalasani, Mazen Noureddin, Michelle Lai, Kenneth Cusi and Eugene R. Schiff and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Nicole Loo

19 papers receiving 622 citations

Hit Papers

Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD:... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Loo United States 10 472 259 168 141 67 25 633
Ewa Gruszewska Poland 13 199 0.4× 141 0.5× 34 0.2× 167 1.2× 71 1.1× 50 505
Shi Chang China 8 100 0.2× 90 0.3× 36 0.2× 154 1.1× 65 1.0× 20 434
Guangyan Wei China 10 138 0.3× 117 0.5× 27 0.2× 158 1.1× 72 1.1× 30 419
Lan Wei United States 12 194 0.4× 175 0.7× 13 0.1× 207 1.5× 49 0.7× 24 559
Annie J. Kruger United States 12 181 0.4× 117 0.5× 53 0.3× 89 0.6× 75 1.1× 20 422
R. Quiles Spain 13 332 0.7× 230 0.9× 22 0.1× 381 2.7× 18 0.3× 20 828
Eun Jin Yoo South Korea 15 254 0.5× 221 0.9× 14 0.1× 141 1.0× 50 0.7× 24 581
G. Marquitan Germany 10 207 0.4× 122 0.5× 28 0.2× 132 0.9× 38 0.6× 12 386
Yoshiko Takata Japan 10 119 0.3× 113 0.4× 38 0.2× 261 1.9× 27 0.4× 16 624
Yvonne Bury United Kingdom 9 120 0.3× 111 0.4× 54 0.3× 100 0.7× 78 1.2× 18 438

Countries citing papers authored by Nicole Loo

Since Specialization
Citations

This map shows the geographic impact of Nicole Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Loo more than expected).

Fields of papers citing papers by Nicole Loo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Loo. The network helps show where Nicole Loo may publish in the future.

Co-authorship network of co-authors of Nicole Loo

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Loo. A scholar is included among the top collaborators of Nicole Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Loo. Nicole Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yuting, Liu Yang, Nicole Loo, et al.. (2024). 6590 Androgen Derived Hepatocellular Adenoma And Reinitiation Of Gender Affirming Hormone Therapy. Journal of the Endocrine Society. 8(Supplement_1).
2.
Huang, Yuting, Nicole Loo, Alice Y. Chang, et al.. (2024). Hepatic Adenomatosis in a Transgender Man on Gender-Affirming Testosterone Therapy. ACG Case Reports Journal. 11(9). e01483–e01483.
3.
Harnois, Denise M., et al.. (2024). Successful treatment of severe passenger lymphocyte syndrome with efgartigimod synergy. Transfusion. 64(4). 755–760.
4.
Thrift, Aaron P., Fasiha Kanwal, Yanhong Liu, et al.. (2023). Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score. PLoS ONE. 18(2). e0282309–e0282309. 13 indexed citations
5.
Harnois, Denise M., et al.. (2022). S3145 Severe Transplantation-Mediated Alloimmune Thrombocytopenia After Liver Transplant Treated Successfully With Efgartigimod. The American Journal of Gastroenterology. 117(10S). e2020–e2020.
6.
Kanwal, Fasiha, Saira Khaderi, Amit G. Singal, et al.. (2022). Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 77(3). 997–1005. 77 indexed citations
7.
Kanwal, Fasiha, Saira Khaderi, Amit G. Singal, et al.. (2022). 530: RISK STRATIFICATION MODEL FOR HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS. Gastroenterology. 162(7). S–1131. 2 indexed citations
8.
Gawrieh, Samer, Mazen Noureddin, Nicole Loo, et al.. (2021). Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial. Hepatology. 74(4). 1809–1824. 261 indexed citations breakdown →
9.
Siddiqui, Mohammad Shadab, Michael O. Idowu, Dhruvanshu Parmar, et al.. (2020). A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology. 19(12). 2670–2672. 64 indexed citations
10.
Kim, Jae, Robert M. Mitchell, Ruben D. Ramirez, et al.. (2020). Sa1537 HIGH SVR RATES IN 1612 PATIENTS WITH MULTIPLE COMORBID MEDICAL CONDITIONS, INCLUDING ESRD, TREATED WITH HCV DAAS IN COMMUNITY PRACTICE USING A SPECIALIZED PHARMACY TEAM. Gastroenterology. 158(6). S–1324. 1 indexed citations
11.
Alkhouri, Naim, et al.. (2020). Cholestasis in Benign Recurrent Intrahepatic Cholestasis 2. ACG Case Reports Journal. 7(6). e00412–e00412. 5 indexed citations
12.
Wells, Jennifer T., Nicole Loo, Carmen Landaverde, et al.. (2020). S0988 Health Outcomes in Patients With Hepatic Encephalopathy Managed Through Telemedicine and a Specialized Pharmacy Team. The American Journal of Gastroenterology. 115(1). S503–S503. 1 indexed citations
13.
Elsaid, Mohamed I., et al.. (2019). The burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease. Journal of Medical Economics. 23(4). 378–385. 6 indexed citations
14.
Loo, Nicole, Eric Lawitz, Naim Alkhouri, et al.. (2019). Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients. World Journal of Gastroenterology. 25(18). 2229–2239. 7 indexed citations
16.
Balakrishnan, Maya, Fernanda Fernandes Souza, Salvador Augustín, et al.. (2016). Liver and Spleen Stiffness Measurements by Point Shear Wave Elastography via Acoustic Radiation Force Impulse. Journal of Ultrasound in Medicine. 35(11). 2373–2380. 30 indexed citations
17.
Wi, Chung‐Il, Nicole Loo, Joseph J. Larson, et al.. (2014). Low Level of Hepatitis B Virus Screening Among Patients Receiving Chemotherapy. Clinical Gastroenterology and Hepatology. 13(5). 970–975. 23 indexed citations
18.
Loo, Nicole, et al.. (2013). 31-Year-Old Woman With Alopecia. Mayo Clinic Proceedings. 88(10). 1147–1150.
19.
Loo, Nicole, Fernanda Fernandes Souza, & Guadalupe García–Tsao. (2013). Non-hemorrhagic acute complications associated with cirrhosis and portal hypertension. Best Practice & Research Clinical Gastroenterology. 27(5). 665–678. 5 indexed citations
20.
Loo, Nicole, et al.. (2012). Exploring hepatitis B: a neglected disease.. PubMed. 95(5). 37–40. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026